- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | L A M Y: Exousia Bio Nearing Completion of Milestone Multimillion-Dollar Capital Investment | 248 | ACCESS Newswire | Strategic Financing to Accelerate Exosome Pipeline Expansion, International Joint Ventures, and Scale-Up of NexTel Medical (MAJI) ORLANDO, FL / ACCESS Newswire / August 4, 2026 / Exousia Bio, Inc. f/k/a... ► Artikel lesen | |
| 22.07. | Exousia Pro, Inc.: NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform | 142 | GlobeNewswire (Europe) | Revised transaction expands NexTel's acquisition from JumpstartRx and NuevistraMed to Island 40 Group's broader growth platform, adding health services, pharmaceutical access, lab testing, institutional... ► Artikel lesen | |
| 16.06. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 09.06. | Exousia Pro, Inc.: NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University | 758 | GlobeNewswire (Europe) | Led by Scientific Advisory Board Members Dr. John Bitzer and Dr. Marvin Hausman, the Study Utilizes Advanced Mass Spectrometry to Identify the Precise Bioactive Healing Compounds Within Proprietary... ► Artikel lesen | |
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 02.06. | Exousia Pro, Inc.: NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome Commercialization | 275 | GlobeNewswire (Europe) | Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026... ► Artikel lesen | |
| 11.05. | Exousia Pro, Inc.: NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist | 260 | GlobeNewswire (Europe) | ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery... ► Artikel lesen | |
| 14.04. | Exousia Bio, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 07.04. | Exousia Pro, Inc.: NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test | 1 | GlobeNewswire (USA) | ||
| 17.03. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 16.03. | Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value | 527 | GlobeNewswire (Europe) | ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 05.03. | Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions | 155 | GlobeNewswire (Europe) | ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce... ► Artikel lesen | |
| 10.02. | Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition | 1 | GlobeNewswire (USA) | ||
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 497 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 452 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 520 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 388 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 540 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 680 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 508 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 549 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 232,20 | +1,18 % | BERNSTEIN RESEARCH stuft Sartorius Vorzuege auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Sartorius anlässlich der jüngst veröffentlichten Halbjahreszahlen von 284 auf 273 Euro gesenkt, die Einstufung... ► Artikel lesen | |
| UNUSUAL MACHINES | 26,030 | 0,00 % | Unusual Machines, Inc.: Unusual Machines Second Quarter 2026 Shareholder Letter | Conference call today at 8:00 a.m. ET ORLANDO, FL / ACCESS Newswire / August 6, 2026 / Unusual Machines (NYSE American:UMAC) ("Unusual Machines" or the "Company"), a leading provider of NDAA-compliant... ► Artikel lesen | |
| SERVE ROBOTICS | 5,080 | -0,10 % | Serve Robotics Inc.: Serve Robotics Announces Second Quarter 2026 Results | Delivered over 400% revenue growth in Q2 year over year as diverse portfolio of revenue across delivery, branding, and software grew strong triple digits compared to a year ago. Further diversified... ► Artikel lesen | |
| PVA TEPLA | 30,060 | +0,54 % | EQS-AFR: PVA TePla AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: PVA TePla AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
PVA TePla AG: Vorabbekanntmachung über die Veröffentlichung... ► Artikel lesen | |
| LIGHTWAVE LOGIC | 8,130 | +0,25 % | Lightwave Logic, Inc. Announces Timing of Second Quarter 2026 Financial Results and Business Update Call | ENGLEWOOD, CO / ACCESS Newswire / August 3, 2026 / Lightwave Logic, Inc. (NASDAQ:LWLG) (the "Company"), a technology platform company leveraging its proprietary electro-optic (EO) polymers to enable... ► Artikel lesen | |
| DRONESHIELD | 1,374 | +0,51 % | Tech- und KI-Aktien im Fokus: Super Micro Computer und Droneshield vor Rebound? Miivo AI formiert sich! | Der Technologiesektor bleibt auch aktuell weiterhin, nicht nur durch die Künstliche Intelligenz, ein faszinierender Ort der Extreme. Während einige Unternehmen eine hohe Auftragsflut vor sich herschieben... ► Artikel lesen | |
| AIRJOULE TECHNOLOGIES | 5,915 | -0,08 % | Why Did AirJoule Stock Pop Today? | ||
| AXON ENTERPRISE | 495,00 | +0,22 % | Axon Enterprise, Inc. Reports Retreat In Q2 Profit | WASHINGTON (dpa-AFX) - Axon Enterprise, Inc. (AXON) reported earnings for second quarter that Drops, from the same period last yearThe company's bottom line came in at $29.427 million, or $0.36... ► Artikel lesen | |
| EVOLV TECHNOLOGIES | 6,125 | -0,08 % | NSE - Evolv Technologies Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| 2G ENERGY | 57,50 | -0,69 % | Kissigs Rückblick 31/2026: Die Kurstreiber in meinem Depot waren Almonty, Rheinmetall, Waste Management, 2G Energy, Texas Pacific Land - und sorgten für ein neues Jahrestief | Die Top-Werte meines Investmentdepots veröffentliche ich jeweils zum Quartalsende in meinen Investor-Updates und meine Beobachtungsliste aktualisiere ich wöchentlich.Ergänzend gebe ich heute eine kurze... ► Artikel lesen | |
| ITURAN LOCATION AND CONTROL | 52,94 | -0,02 % | Dividendenbekanntmachungen (24.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AH REALTY TRUST INC US04208T1088 0,14 USD 0,1229 EUR AMBEV SA ADR US02319V1035 0,0091 USD 0,008 EUR ARLANDASTAD GROUP AB SE0016276851 1... ► Artikel lesen | |
| GPGI | 14,990 | 0,00 % | GPGI reiterates FY 2026 guidance with $1.95B-$2.1B net sales and targets 3x leverage by end of 2026 | ||
| WRAP TECHNOLOGIES | 1,870 | 0,00 % | Wrap Technologies startet neue Schulungsplattform WrapTactics | ||
| HUDSON TECHNOLOGIES | 5,600 | +0,09 % | HUDSON TECHNOLOGIES INC /NY - 10-Q, Quarterly Report | ||
| KRATOS DEFENSE | 52,58 | -0,02 % | Kratos wins U.S. Army contract to develop enhanced Javelin seeker |
EXOUSIA ADVANCED MATERIALS INC gehört der Branche Sonstige Technologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.